Clinically-Related 483s and Warning Letters: Getting through the Maze (Clinical Compliance )

Venue: Online Event

Location: Palo Alto, California, United States

Event Date/Time: Dec 08, 2011 End Date/Time: Dec 08, 2011
Report as Spam


By the end of this webinar, the participant will have an understanding of the context for clinical site FDA inspections and the issues that may arise. Effective handling of these issues during the inspection can reduce the risk of further regulatory action. Should observations (“483”) and/or a Warning Letter be issued, participants will have an enhanced understanding how and the timing required to respond, and how to avoid further regulatory action by the Agency.

Areas Covered in the Seminar:

- Managing FDA inspections.
- Understanding observations.
- Providing a written response.
- Responding to observations (“483”).
- Responding to a Warning Letter.
-Dealing with the ramifications.

NOTE : Use this Promocode (128600)to avail 10% discount,Valid till December 30 & add another webinar to your shopping cart and get 20% off on its price.


Online Event
2600 E. Bayshore Road
Palo Alto
United States